"To bring together the world of finance and the world of science”( Thursday, 15 November 2007 )
Commercialization of research and basic science is the most difficult issue the world over. India has done tremendously well in bulk manufacturing drugs during the process patent era. However a far bigger opportunity is available for the country in the coming decades both in the biogenerics and drug discovery process because of a multitude of factors. India can be the medicines supplier to the entire world.
Also innovation occurs at the intersection of similar industries. Where innovation is there, there will be a financial opportunities. It is up to us to grab that. However there has to be a better understanding between the innovators and the financial world to take ideas come to market place.
11.30 to 11.40
Track Chair
Dr. Ramesh, Medwin Hospital; Baseline Partners, Dr. Srinivas Akkaraju, Panorama Capital
11.40 to 12.00
Keynote
Bobba Venkatadri, VenturEast Fund Advisors & Trans-India Acquisition Corporation
